Group 1 - The stock of Huason Pharmaceutical has reached a limit-up, marking three consecutive limit-up days, with a current price of 18.80 yuan and a turnover rate of 8.06% [2] - During the consecutive limit-up period, the stock has increased by 33.05%, with a cumulative turnover rate of 22.87% [2] - The latest total market capitalization of the A-shares is 78.51 billion yuan, with a circulating market capitalization of 58.07 billion yuan [2] Group 2 - The stock has appeared on the Dragon and Tiger List due to a cumulative deviation of 20% in its price over three trading days, with institutional net purchases amounting to 3.3683 million yuan and a total net sale by the Shenzhen Stock Connect of 32.3933 million yuan [2] - The company reported a total operating revenue of 239 million yuan for the first quarter, representing a year-on-year growth of 4.62%, and a net profit of 40 million yuan, with a slight increase of 0.01% year-on-year [2] Group 3 - Recent trading data shows significant fluctuations in daily price changes and net inflows of main funds, with the highest daily increase recorded at 9.97% on May 28, 2025, and a net inflow of 59.923 million yuan [2] - The stock has experienced varying turnover rates, with the highest at 11.94% on the same day, indicating active trading [2]
华森制药连收3个涨停板